Scopia Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-749,538
Closed -$126M 29
2019
Q1
$126M Sell
749,538
-595,660
-44% -$88.6M 4.67% 9
2018
Q4
$131M Sell
1,345,198
-142,109
-10% -$18.6M 4.44% 9
2018
Q3
$257M Sell
1,487,307
-550,818
-27% -$79.4M 4.94% 8
2018
Q2
$284M Sell
2,038,125
-677,062
-25% -$96.2M 4.97% 6
2018
Q1
$306M Sell
2,715,187
-739,867
-21% -$93M 6.12% 4
2017
Q4
$456M Buy
3,455,054
+467,035
+16% +$54.9M 8.18% 3
2017
Q3
$303M Buy
2,988,019
+493,281
+20% +$52.8M 4.79% 7
2017
Q2
$250M Buy
2,494,738
+506,421
+25% +$54.5M 5.16% 7
2017
Q1
$240M Sell
1,988,317
-96,250
-5% -$11.8M 4.44% 11
2016
Q4
$233M Buy
2,084,567
+199,400
+11% +$24M 4.41% 8
2016
Q3
$250M Buy
1,885,167
+407,458
+28% +$38.9M 4.41% 10
2016
Q2
$135M Buy
+1,477,709
New +$124M 2.79% 14

Other funds holding GWPH

Scopia Capital Management's GWPH Position: Q2 2019 in Review

Scopia Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2019, closing a stake of 749,538 shares — an estimated $126M sold.

Scopia Capital Management first reported a position in GWPH in Q2 2016 and held it in 12 quarters. The position peaked at $456M in Q4 2017. 318 funds tracked by Wall St. Rank hold GWPH as of Q2 2019.

  • Scopia Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
  • Scopia Capital Management sold 749,538 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2019, an estimated $126M.
  • Scopia Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2016 and held it in 12 quarters.
  • Scopia Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $456M in Q4 2017.
  • 318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2019.

Based on Scopia Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.